CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
12.97
+0.46 (3.68%)
At close: Aug 22, 2025, 4:00 PM
12.85
-0.12 (-0.93%)
After-hours: Aug 22, 2025, 7:45 PM EDT
CareDx Stock Forecast
Stock Price Forecast
The 6 analysts that cover CareDx stock have a consensus rating of "Buy" and an average price target of $27.67, which forecasts a 113.34% increase in the stock price over the next year. The lowest target is $14 and the highest is $40.
Price Target: $27.67 (+113.34%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CareDx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 7 | 7 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Hold Maintains $19 → $14 | Hold | Maintains | $19 → $14 | +7.94% | Aug 8, 2025 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $40 → $26 | Strong Buy | Maintains | $40 → $26 | +100.46% | Jul 18, 2025 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $40 | Buy | Reiterates | $40 | +208.40% | May 5, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $25 | Hold | Reiterates | $25 | +92.75% | May 5, 2025 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $34 → $26 | Strong Buy | Maintains | $34 → $26 | +100.46% | Apr 17, 2025 |
Financial Forecast
Revenue This Year
377.25M
from 333.79M
Increased by 13.02%
Revenue Next Year
425.71M
from 377.25M
Increased by 12.85%
EPS This Year
0.57
from 0.93
Decreased by -38.80%
EPS Next Year
0.95
from 0.57
Increased by 67.38%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 392.6M | 451.0M | 504.1M |
Avg | 377.3M | 425.7M | 470.8M |
Low | 359.9M | 386.5M | 427.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 17.6% | 19.5% | 18.4% |
Avg | 13.0% | 12.8% | 10.6% |
Low | 7.8% | 2.5% | 0.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.62 | 1.17 | 2.53 |
Avg | 0.57 | 0.95 | 1.48 |
Low | 0.49 | 0.72 | 0.87 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | -33.4% | 104.8% | 165.4% |
Avg | -38.8% | 67.4% | 55.5% |
Low | -47.3% | 25.7% | -8.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.